Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | MAOA | P21397 | 3/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | AHR | P35869 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | NQO1 | P15559 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3368451 | 0.84 | MAOA (0.61) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL16668859 | 0.84 | — | — | |
| SCHEMBL11525579 | 0.80 | — | — | |
| SCHEMBL1336761 | 0.80 | — | — | |
| SCHEMBL29186477 | 0.77 | IDO1 (0.38) | KDM4EALDH1A1SMN1; SMN2HPGDMAOA | |
| SCHEMBL8105692 | 0.77 | ALDH1A1 (0.34) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL25356838 | 0.77 | KDM4E (0.40) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| SCHEMBL5099 | 0.76 | MAOA (0.48) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| Dibenzofuran SCHEMBL8207 | 0.72 | MAPT (0.68) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD | |
| Dibenzofuran SCHEMBL9868133 | 0.72 | MAPT (0.68) | KDM4EALDH1A1MAPTSMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2052 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118284595-A | Arylamine compound, organic electroluminescent element, and electronic device | 保土谷化学工业株式会社 | 2024-07-02 | — | — | CN | claimed |
| EP-4387978-A1 | 7-SUBSTITUTED 7-DEAZAADENINE-CONTAINING 2',3'-CYCLIC DINUCLEOTIDES | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2024-06-26 | — | — | EP | claimed |
| WO-2024121084-A1 | PREPARATION OF NITRILES | MERCK PATENT GMBH (DE) | 2024-06-13 | — | — | WO | claimed |
| CN-118027082-A | Electronic unit and conjugated polymer based on oxygen-boron-nitrogen coordination bond and preparation method thereof | 中国科学院长春应用化学研究所 | 2024-05-14 | — | — | CN | claimed |
| CN-117756767-A | Preparation method of gamma, gamma-difluoroallylaldehyde compound and derivative thereof | 南京林业大学 | 2024-03-26 | — | — | CN | claimed |
| EP-3749631-B1 | TRIARYLMETHANE COMPOUNDS | MITSUBISHI GAS CHEMICAL CO (JP) | 2024-03-06 | — | — | EP | claimed |
| US-11917906-B2 | Compounds that can be used in an organic electronic device | MERCK PATENT GMBH (DE) | 2024-02-27 | — | — | US | claimed |
| US-20240049591-A1 | DINUCLEAR PLATINUM COMPLEXES FOR OLED APPLICATION | THE UNIVERSITY OF HONG KONG (CN) | 2024-02-08 | — | — | US | claimed |
| EP-4311851-A1 | DINUCLEAR PLATINUM COMPLEXES FOR OLED APPLICATIONS | The University Of Hong Kong (CN) | 2024-01-31 | — | — | EP | claimed |
| CN-117466947-A | Binuclear platinum complexes for OLED applications | 香港大学 | 2024-01-30 | — | — | CN | claimed |
| EP-0754184-A1 | CEPHALOSPORIN ANTIBIOTICS | Microcide Pharmaceuticals, Inc. (US) | 1997-01-22 | — | — | EP | claimed |
| WO-1996002517-A1 | SUBSTITUTED ARYLSULFONAMIDES, THEIR PREPARATION AND USE AS THROMBIN-INHIBITING MEDICAMENTS | DR. KARL THOMAE GMBH (DE) | 1996-02-01 | — | — | WO | claimed |
| WO-1995026966-A1 | CEPHALOSPORIN ANTIBIOTICS | MICROCIDE PHARMACEUTICALS, INC. (US) | 1995-10-12 | — | — | WO | claimed |
| US-5254546-A | Hypotensive agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-10-19 | — | — | US | claimed |
| EP-0524946-A4 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | — | 1993-03-24 | — | — | EP | claimed |
| EP-0524946-A1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1993-02-03 | — | — | EP | claimed |
| EP-0479892-A1 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1992-04-15 | — | — | EP | claimed |
| WO-1991015206-A1 | TREATMENT OF GLAUCOMA AND OCULAR HYPERTENSION WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-17 | — | — | WO | claimed |
| WO-1991014367-A1 | TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS WITH IMIDAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-10-03 | — | — | WO | claimed |
| WO-1991000281-A2 | FUSED-RING ARYL SUBSTITUTED IMIDAZOLES | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-01-10 | — | — | WO | claimed |